Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

In December 2024, we received approval to initiate our Phase 1b clinical trial of GT-02287 in people with GBA1 or idiopathic Parkinson’s disease. This followed the completion of our study in healthy ...

In December 2024, we received approval to initiate our Phase 1b clinical trial of GT-02287 in people with GBA1 or idiopathic Parkinson's disease. This followed the completion of our study in healthy ...

Medicare covers deep brain stimulation (DBS) to treat Parkinson’s disease or essential tremor when a doctor deems it medically necessary and when a person meets the coverage criteria.

Ozzy Osbourne is “very happy” about his forthcoming final concert even if his battle with Parkinson’s disease continues to take a physical toll, according to his wife. Sharon Osbourne ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

Onapgo, a subcutaneous apomorphine infusion device, is approved for advanced Parkinson's disease, offering continuous symptom management without surgery. The TOLEDO trial showed apomorphine ...

And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...